Showing results (21-30 of 35) with videos related to

Sort By:
Pageof 4
The Journal of Veterinary Medical Science|December 11, 2003
Development of an efficient method for recovery of Puumala and Puumala-related viruses by inoculation of Mongolian gerbilsNandadeva Lokugamage, Hiroaki Kariwa, Kumari Lokugamage, et al.
Vaccine|November 17, 2012
Safety and immunogenicity of recombinant Rift Valley fever MP-12 vaccine candidates in sheepJohn C Morrill, Richard C Laughlin, Nandadeva Lokugamage, et al.
The Japanese Journal of Veterinary Research|April 9, 2004
Comparison of virulence of various hantaviruses related to hemorrhagic fever with renal syndrome in newborn mouse modelKumari Lokugamage, Hiroaki Kariwa, Nandadeva Lokugamage, et al.
Virus Research|March 26, 2004
Genetic and antigenic characterization of the Amur virus associated with hemorrhagic fever with renal syndromeKumari Lokugamage, Hiroaki Kariwa, Nandadeva Lokugamage, et al.
Viruses|May 26, 2016
N-Glycans on the Rift Valley Fever Virus Envelope Glycoproteins Gn and Gc Redundantly Support Viral Infection via DC-SIGNInaia Phoenix, Shoko Nishiyama, Nandadeva Lokugamage, et al.
Plos Neglected Tropical Diseases|May 3, 2013
Characterization of Rift Valley fever virus MP-12 strain encoding NSs of Punta Toro virus or sandfly fever Sicilian virusOlga A Lihoradova, Sabarish V Indran, Birte Kalveram, et al.
Journal of Virology|May 8, 2015
Rift Valley Fever Virus MP-12 Vaccine Is Fully Attenuated by a Combination of Partial Attenuations in the S, M, and L SegmentsTetsuro Ikegami, Terence E Hill, Jennifer K Smith, et al.
Virulence|June 2, 2016
Attenuation of pathogenic Rift Valley fever virus strain through the chimeric S-segment encoding sandfly fever phlebovirus NSs or a dominant-negative PKRShoko Nishiyama, Olga A L Slack, Nandadeva Lokugamage, et al.
Vaccine|December 27, 2015
Rift Valley fever MP-12 vaccine Phase 2 clinical trial: Safety, immunogenicity, and genetic characterization of virus isolatesPhillip R Pittman, Sarah L Norris, Elizabeth S Brown, et al.
Journal of Virology|May 11, 2012
The dominant-negative inhibition of double-stranded RNA-dependent protein kinase PKR increases the efficacy of Rift Valley fever virus MP-12 vaccineOlga Lihoradova, Birte Kalveram, Sabarish V Indran, et al.
Pageof 4